Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
30-Sep-23 | Interim | 193.25 | 30.86 | 22.40p | 8.20p |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-19 | 151.29 | 21.12 | 15.90p | 34.7 | 0.6 | +59% | 9.30p | 1.7% |
31-Mar-20 | 178.78 | 23.15 | 17.10p | 38.5 | 4.8 | +8% | 3.50p | 0.5% |
31-Mar-21 | 234.69 | 50.34 | 0.38p | 3,973.4 | n/a | -98% | 0.22p | 0.0% |
31-Mar-22 | 302.63 | 45.99 | 38.90p | 34.0 | 0.0 | +10,260% | 22.20p | 1.7% |
31-Mar-23 | 374.81 | 54.34 | 43.10p | 32.1 | 2.9 | +11% | 23.90p | 1.7% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-24 | 394.89 | 72.05 | 45.04p | 21.1 | 4.7 | +4% | 25.02p | 0.0% |
31-Mar-25 | 428.46 | 81.45 | 50.14p | 18.9 | 1.7 | +11% | 27.64p | 0.0% |
31-Mar-26 | 478.29 | 91.77 | 57.16p | 16.6 | 1.2 | +14% | 29.78p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 34.72 | 32.06 | 822.53 | 0.03 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 950.00p |
Change Today | 21.00p |
% Change | 2.26 % |
52 Week High | 1,417.00p |
52 Week Low | 914.00p |
Volume | 174,781 |
Shares Issued | 125.79m |
Market Cap | £1,194.98m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 4 |
Neutral | 2 |
Sell | 1 |
Strong Sell | 0 |
Total | 9 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 23-Nov-23 | 28-Sep-23 |
Paid | 15-Dec-23 | 20-Oct-23 |
Amount | 8.20p | 16.10p |
Time | Volume / Share Price |
16:48 | 731 @ 949.65p |
16:35 | 81,096 @ 950.00p |
16:35 | 69 @ 950.00p |
16:35 | 173 @ 950.00p |
16:35 | 927 @ 950.00p |
CFO | Richard McCann |
Chair | Tom Burnet |
CEO | Russell Sloan |
You are here: research